Guest guest Posted May 13, 2008 Report Share Posted May 13, 2008 Frightening here - vaccines for the common cold.. http://news.bbc.co.uk/2/hi/health/526904.stm Cold 'cure' comes one step closer Progress is slow towards a common cold cure US scientists believe they have found a way of blocking one of the principal viruses that causes cold symptoms in adults. Their research has successfully stopped viruses from binding with human cells in a test tube. If the virus cannot bind with a cell, it cannot enter the cell and reproduce, which should stop or at least slow its progress. However, the successful production of a cold " vaccine " is still a long way off - as conditions in a test tube differ greatly from those in the average human nose. The report comes from the US Department of Energy's Brookhaven National Laboratory, and is published in the journal Science. Scientists managed to tailor the bacterium E.coli, which can cause food poisoning in some forms, but also helps to break down food in the gut, so that it mimicked the cell protein which joins with the virus. The theory is that a vaccine created from millions of these proteins would make viruses bind to these rather than the cells. 'Dead in the water' Biologist Freimuth, who worked on the project, said: " Viruses have to bind to cells in order to infect them. " If you could interrupt that binding, the virus would be dead in the water. " The virus at the centre of this work was the adenovirus, which accounts for less than 50% of human cold infections. The vaccine would work in the same way as the antibodies naturally produced by the body's immune system, but work more quickly. Gene therapy The team are hoping that a precise knowledge of the binding mechanism will help other scientists use deactivated cold viruses to carry gene therapy into diseased or damaged cells. Many teams are working on therapies for cancer and lung diseases such as cystic fibrosis which use adenoviruses as the method of carrying their altered genes. The limitations of " vaccines " for cold viruses are the methods of getting them to the cells concerned in the nose and throat. The Common Cold Centre, based at the University of Wales in Cardiff, has conducted similar research on rhinoviruses, which cause between 30 and 40% of colds. They found that while the technique worked well in a test tube, it was far less effective in a live human, as the medication tended not to settle in the nose for long enough to mop up all the virus. Dangerous for the young Although the common cold is only a minor irritation to most adults who contract it, it can have more serious consequences for babies. Dr Mackie, the principal clinical virologist at Yorkhill NHS Trust in Glasgow, is currently witnessing a mini-epidemic of respiratory syncytial virus infections which cause extreme breathing difficulties to younger babies. " An effective treatment for these viruses would be extremely useful, " he said. " We have had more than 50 cases of respiratory syncytial virus infections in infants quite recently. " -- (and this one's about Zicam - it uses zinc.. Why not just take 50mg a day instead of waiting until you have a cold to spray it up your nose?) http://news.bbc.co.uk/2/hi/health/502943.stm Spray could cut cold misery Colds can last for days The effects of a cold could be wiped out in just over a day using a nasal spray containing zinc, according to researchers in the US. Drug companies have been testing the spray - which is already available in the US as a homeopathic medication - in clinical trials and found that it reduced the average length of a cold from almost ten days to 36 hours.. However, specialists investigating the common cold warned that it was too early to tell if the treatment would be genuinely useful. The spray - known as Zicam - is being developed by Gel-Tech, a joint venture between three US companies. Promising results " This initial clinical research showed that participants who used Zicam at the onset of symptoms significantly reduced the duration of their colds, " said Dr Hensley, head of research at Gel-Tech. The researchers looked at 104 people who had suffered cold symptoms for up to 24 hours and gave them either Zicam or a dummy spray to use four times a day. Those using the dummy spray suffered sneezing, runny noses and other symptoms for an average of 9.8 days compared with 1.5 days for the others. The medicine had " no known side effects, " was described as " soothing " and could be used by children as young as three, a company spokesman said. Zinc has been used to tackle the common cold before, but while some studies have shown zinc lozenges to be effective, there have been problems developing a spray. Tolerable formula Professor Ron Eccles, head of the Common Cold Centre in Cardiff, said zinc may prevent viruses that cause colds from attacking cells. [ image: Ron Eccles said zinc can block the virus] Ron Eccles said zinc can block the virus " Quite a bit of work has been done on zinc nasal sprays in the past, but most people have found them irritating, " he told BBC News Online. " So it's interesting that they've got a formulation that is well tolerated. " However, he said the results should be interpreted with caution. " It's a first report, and obviously the company does have a commercial interest in it being good, " he said. " We shouldn't read too much into it until the full results have been published and independently studied. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.